What is TAGRISSO (Osimertinib Capsules)
It is a kinase inhibitor
Company that Manufactures/ Markets:
M/s AstraZeneca Pharmaceuticals
80 mg and 40 mg (Osimertinib Tablets)
Its use and Indications
Tagrisso (Osimertinib) is indicated for the treatment of patients with Metastatic Epidermal Growth Factor (EGFR) T790M mutation-positive non-small cell Lung Cancer (NSCLC)
For treatment related information, please consult your treating Physician.
Tagrisso 80 mg and 40 mg Tablets are available in bottles of 30’s
Storage and handling
Store at 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Contact us @ +91 7678048225 or by email email@example.com.